From 23 June 2025, people living with obesity and four or more diagnosed health conditions will begin to have the opportunity to access tirzepatide (Mounjaro®) for weight loss support through their GP/Primary Care services.
This process will be managed through the practice directly contacting people who are eligible, this does not mean that prescriptions will be given out immediately. Practices will be contacting people who have been identified as eligible over the coming weeks. Read more about eligibility for tirzepatide (Mounjaro®) – Please do not contact the practice directly, if you feel you are eligible please wait to be contacted by the Carden Surgery.
Full qualifying criteria is a BMI (Body Mass Index) of 40 or greater and four or more of the following diagnosed health conditions:
- type 2 diabetes
- Hypertension
- Cardiovascular disease
- Obstructive sleep apnoea
- Dyslipidaemia
We understand that some people may feel frustrated or disappointed if they are not eligible for medication-based treatments at this stage. Living with obesity can be emotionally and physically challenging, and it is completely normal to experience a range of feelings when seeking support for your health. If you are finding things difficult, NHS Talking Therapies offers free and confidential help for people who may be struggling with low mood, anxiety or other emotional pressures.
To find out more about obesity treatment and the support available on the NHS Sussex website. You can also learn more about local support by speaking to your GP or healthcare team.
You can also read the following for more information: